Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
RadNetFRA:PQIA +1.56%78 FCF Margin % is 6.07% as of Jun. 2026, which is 90% above its 10-year median of 3.20. GuruFocus rates FRA:PQIA with a GF Score™ of 78/100 and a GF Value™ of €58.91 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, RadNet ranks better than 57.43% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. RadNet's Free Cash Flow for the
three
months ended in Jun. 2026 was €33 Mil. RadNet's Revenue for the
three
months ended in Jun. 2026 was €541 Mil. Therefore, RadNet's FCF Margin % for the quarter that ended in Jun. 2026 was 6.07%.
The historical rank and industry rank for RadNet's FCF Margin % or its related term are showing as below:
FRA:PQIA'
s FCF Margin % Range Over the Past 10 Years
Min: 0.49 Med: 3.2 Max: 13.02
Current: 3.2
During the past 13 years, the highest FCF Margin % of RadNet was 13.02%. The lowest was 0.49%. And the median was 3.20%.
FRA:PQIA's FCF Margin % is ranked better than 57.43% of 202
companies
in the Medical Diagnostics & Research industry
Industry Median: -0.41
vs FRA:PQIA: 3.20
The historical data trend for RadNet's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PQIA vs SHC, VCYT, TWST: FCF Margin % Comparison
For the Diagnostics & Research subindustry, RadNet's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RadNet FCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, RadNet's FCF Margin % distribution charts can be found below:
* The bar in red indicates where RadNet's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RadNet (FRA:PQIA) has a FCF Margin % of 6.07% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on RadNet and its competitors. This is 90% above median its historical median of 3.20. Over the past decade, RadNet's FCF Margin % has ranged from 0.49 to 13.02. According to the industry distribution chart, RadNet ranks #86 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 42.6%.
Is RadNet's FCF Margin % too high?
RadNet's current FCF Margin % of 6.07% is 90% above median its 10-year median of 3.20. Over the past 10 years, this metric has ranged from a low of 0.49 to a high of 13.02. Based on the distribution chart, RadNet ranks #86 out of 202 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, RadNet has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does RadNet's FCF Margin % compare to SHC and VCYT?
According to the Medical Diagnostics & Research industry distribution chart, RadNet ranks #86 out of 202 companies for FCF Margin %. This puts RadNet in the upper half of its industry. Historically, RadNet's own FCF Margin % has ranged from 0.49 to 13.02 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on RadNet and its competitors. RadNet's current FCF Margin % is 6.07%, which is 90% above median its own 10-year median of 3.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RadNet stock overvalued right now?
Based on GuruFocus' analysis, RadNet (FRA:PQIA) is currently considered Modestly Overvalued. The stock's GF Value™ is €58.91, compared to a current price of €65.24 — trading 10.7% above its estimated fair value. The current FCF Margin % is 6.07%, which is 90% above median its 10-year median of 3.20. RadNet's overall GF Score™ is 78/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For RadNet (FRA:PQIA), the current FCF Margin % is 6.07% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RadNet (FRA:PQIA) Overvalued in 2026?
Based on GuruFocus' analysis, RadNet stock appears to be overvalued.
The current stock price of €65.24 is trading 10.7% above its estimated GF Value™ of €58.91.
GuruFocus considers RadNet to be Modestly Overvalued.
Key valuation signals for FRA:PQIA:
FCF Margin %: 6.07% (90% above median its 10-year median of 3.20)
GF Value™: €58.91 vs. price of €65.24 (10.7% above fair value)
No single metric tells the full story. See the FRA:PQIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
78GF Score
Get the complete analysis for FRA:PQIA
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PQIA has been successfully added to your 
